- 11,573$2.9B
1
- 11,851$12.2B
2
- 83,100$41.5B
3
- 27,584$5.6B
4
- 34,300$46.2B
5
- 13,500$2.9B
6
CSL
Manufacturing · Australia · 32,065 Employees
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Today, CSL including our three businesses, CSL Behring, CSL Seqirus andCSL ViforRead More
View Company Info for Free
Who is CSL
Headquarters
Phone Number
Website
Revenue
Stock Symbol
Industry
Top Competitors of CSL
CSL Org Chart
CSL Email Formats
CSL uses at least 5 email formats with first.last (ex. John.Smith@csl.com.au) being used 49.9% of the time
CSL Email Formats | Percentage | |
---|---|---|
first.last | John.Smith@csl.com.au | 49.9% |
first.last | John.Smith@cslplasma.com | 25.7% |
first.last | John.Smith@cslbehring.com | 5.9% |
first.last | John.Smith@cslbehring.com.au | 3% |
first.last | John.Smith@cslships.com | 2.9% |
Get Verified Emails
CSL Company Metrics
Jul 18, 2022
Seqirus UK
Jul 18, 2022
Seqirus UK
Aug 06, 2016
Vitaeris
May 06, 2016
Inositec
Mar 12, 2012
Sanifit
Nov 20, 2009
CSL Vifor
See More Acquisitions & Subsidiaries
Top Companies in Australia
Top 10 companies in Australia by revenue
Top 10 companies in Australia by number of employees
Top 10 companies in Australia by total funding amount
CSL News & Media
Carlisle Companies, Inc. (CSL) Q3 2023 Earnings Call Transcript
Carlisle Companies, Inc. (NYSE:NYSE:CSL) Q3 2023 Earnings Conference Call October 26, 2023 5:00 PM ETCompany ParticipantsMehul Patel - VP, IRChristian Koch...CSL Limited's (ASX:CSL) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 9.7% over the past three months, it is easy to disregard CSL (ASX:CSL). However, stock prices are...CSL Signs Renewable-Linked Power Purchase Agreement with AGL to Supply Electricity to Australian Manufacturing Sites
MELBOURNE, Australia, Oct. 12, 2023 /PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) announced today that it has signed a Renewable-Linked Power Purchase Agreement (PPA) with Australian energy provider, AGL. AGL was awarded the contract after an extensive review of the energy market. The agreement will significantly advance CSL's Scope 1 & 2 emissions reductions with all electricity used by CSL's Australian manufacturing sites matched by renewable electricity certificatesNew Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines
Data evaluating the impact of cell-based quadrivalent influenza vaccines suggests an additional 31%–39% of influenza cases may have been prevented among persons 0–64 years of age during the 2017-2020 U.S. flu seasons.1 Vaccination of children 6 months to 17 years of age with cell-based...
Frequently Asked Questions regarding CSL
CSL is a global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Today, CSL including our three businesses, CSL Behring, CSL Seqirus and CSL Vifor... Read More